This is in accordance with the work of Johansson and colleagues showing that tumor vasculature‐targeted TNF (via an RGR peptide) improved tumor vessel function and reduced leakiness in a Rip1‐Tag5 pancreatic tumor model (Johansson et al, 2012). This evidence concerns the gene TNF and neoplasm.